HiperCKemia-MB por macroCK tipo 1: reporte de caso

Silvestri, 2013, Asymptomatic/pauci-symptomatic creatine kinase elevations (Hyperckemia), Muscle Nerve, 47, 805, 10.1002/mus.23755 Brancaccio, 2007, Creatine kinase monitoring in sport medicine, Br Med Bull., 81-82, 209, 10.1093/bmb/ldm014 Rosa-Jiménez, 1997, Macrocreatincinasa tipo 1 como causa de aumento de la isoenzima CK-MB. A propósito de 7 casos, Rev Esp Cardiol, 50, 166, 10.1016/S0300-8932(97)73199-3 Coral Alvarado, 2006, HiperCKemia asintomática benigna, Rev Colomb Reumatol, 13, 235 Sturk, 1990, Macro enzymes: prevalence, composition, detection and clinical relevance, J Clin Chem Clin Biochem, 28, 65 Ruelland, 1989, Interference of macrocreatine kinase in determination of CK-MB in serum with the Kodak Ektachem, Clin Chem, 35, 2155, 10.1093/clinchem/35.10.2155 Kleppe, 1995, Findings in 100 patients with idiopathic increase in serum creatine kinase activity [Article in German], Med Klin (Munich), 90, 623 Murthy, 1993, Identification of false-positive CK-MB activity in an elderly patient, Am J Clin Pathol, 99, 97, 10.1093/ajcp/99.1.97 Wu, 1983, Macrocreatine kinase types 1 and 2: Clinical significance in neonates and children as compared with adults, Clin Chem, 29, 201, 10.1093/clinchem/29.1.201 Kaldis, 1995, Functional differences between dimeric and octameric mitochondrial creatine kinase, Biochem J, 308, 623, 10.1042/bj3080623 Galarraga, 2002, A rare but important cause for a raised serum creatine kinase concentration: Two case reports and a literature review, Rheumatology (Oxford), 42, 186, 10.1093/rheumatology/keg039 Lee, 1994, Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data, Clin Chem, 40, 1278, 10.1093/clinchem/40.7.1278 Gadsden, 1994, Analytical evaluation of methods for serum creatine kinase-MB, Ann Clin Lab Sci, 24, 110